Vermont

An Early Look at Vermont’s Value-Based, Multi-Payer “Next Gen” Model, Designed to Lower Costs and Improve Population Health

By Robin Lunge, JD, MHCDS Robin Lunge is a member of Vermont’s Green Mountain Care Board, which regulates health insurance rates, hospital budgets, and accountable care organizations. In this brief, she explores how the state’s transformation from a fee-for-service payment system to a value-based, multi-payer model designed to curb health care spending and improve care […]

Read More
  • Four More States Submit Bills to Import Prescription Drugs from Canada
    State Health Policy Blog

    As states pursue a wide range of legislation to address rising drug costs, four more states have joined Utah and Vermont to introduce bills to import prescription drugs from Canada through a state-run, wholesale operation. This market-based approach to providing more affordable medicines from Canada, where prescription drugs cost on average 30 percent less than […]

    Read More
  • Publications,State Health Policy Blog

    In this time of changing federal health priorities, state health policymakers play a crucial role in breaking the cycle of poverty and inequity so everyone can live healthy, prosperous lives. Many state leaders, with federal support, are implementing community-wide prevention initiatives that acknowledge that health is affected by factors that extend beyond clinical care. Policymakers […]

    Read More
  • State Health Policy Blog

    The Centers for Medicare & Medicaid Services (CMS) recently released its third annual evaluation of the State Innovation Model (SIM) Round One Test States, which analyzes the ability of states to use policy and regulatory levers to drive statewide health care transformation. The evaluation, completed by a team of researchers from RTI International, the Urban […]

    Read More
    September 26, 2017 | Filed under: Blog Posts, Front Page, Maine, Minnesota, State Health Policy Blog, Vermont
  • Lowering Drug Costs: Transparency Legislation Sets Off Flurry of New State Approaches
    State Health Policy Blog

    Responding to rapidly rising drug costs, 30 states across the country have drafted more than 60 drug price transparency bills designed to: Identify the costs that contribute to drug manufacturer expenses and list prices And unveil the often opaque business practices of pharmacy benefit managers (PBMs). In addition to promoting pricing transparency, as of early […]

    Read More
  • On Monday, July 10th, the Centers for Medicare and Medicaid Services (CMS) released a tally of issuer submissions to offer individual market coverage through the Federally-facilitated Exchange. The National Academy for State Health Policy (NASHP) conducted an analysis of preliminary rate filings for states that have opted to run a State-based Exchange (SBE), finding that […]

    Read More
  • Wednesday, October 25th 9:15AM-10:45AM Under a new Administration, there has been increased focus on the need for more flexible federal funding for state health programs. This session examines the implications of braiding, blending, or block granting traditional Medicaid and public health funding streams to support population health goals. Speakers share their own states’ braiding and […]

    Read More
  • State Health Policy Blog

    Post-election, federal leaders are debating changes to the ACA (Affordable Care Act) and whether it will continue in light of the goals put forth by the incoming Administration. Meanwhile, open enrollment for the health insurance marketplaces is in full swing, with some states reporting increased or record enrollment figures during these first weeks of enrollment […]

    Read More
  • Publications

    States are testing a myriad of models that strive to achieve the Triple Aim objectives of improved care, reduced health care costs, and better health. Though several statewide health care delivery and payment system reforms have been shown to help slow the growth of health care expenditures and improve methods for delivering health care, taken […]

    Read More
  • State Health Policy Blog

    On May 10, 2016, Connecticut Governor Dannel Malloy signed legislation limiting most first-time opioid prescriptions to seven days (Pub. Act 16-43). The Vermont General Assembly passed a similar bill earlier this month, which will require the state’s Health Commissioner to adopt rules governing opioid prescribing. (Note: The Vermont law was passed during the final week […]

    Read More
    May 17, 2016 | Filed under: Connecticut, State Health Policy Blog, Vermont